Mackenzie Financial Corp Amneal Pharmaceuticals, Inc. Transaction History
Mackenzie Financial Corp
- $66.8 Billion
- Q3 2024
A detailed history of Mackenzie Financial Corp transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 12,221 shares of AMRX stock, worth $109,989. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,221
Previous 22,138
44.8%
Holding current value
$109,989
Previous $140,000
27.86%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding AMRX
# of Institutions
185Shares Held
141MCall Options Held
57KPut Options Held
49K-
Ubs Group Ag21.8MShares$196 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.6MShares$132 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$111 Million2.45% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$102 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$96.5 Million2.48% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.36B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...